Vanguard Global Advisers
IART icon

Vanguard Global Advisers’s Integra LifeSciences IART Stock Holding History

Vanguard Global Advisers’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.02M Sell
168,094
-20,327
-11% -$284K ﹤0.01% 1011
2026
Q1 		$1.77M Buy
+188,421
New +$2.07M ﹤0.01% 1271

Other funds holding IART

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Vanguard Global Advisers's IART Position: Q2 2026 in Review

Vanguard Global Advisers reduced its Integra LifeSciences (IART) stake by 11% in Q2 2026, selling an estimated $284K and leaving 168,094 shares worth $3.02M. The position accounts for ﹤0.01% of the portfolio, ranked #1011.

Vanguard Global Advisers first reported a position in IART in Q1 2026 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold IART as of Q2 2026.

  • Vanguard Global Advisers held 168,094 shares of Integra LifeSciences worth $3.02M as of Q2 2026.
  • Vanguard Global Advisers sold 20,327 Integra LifeSciences shares in Q2 2026, an estimated $284K.
  • Integra LifeSciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #1011 holding.
  • Vanguard Global Advisers first reported a position in Integra LifeSciences in Q1 2026 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.